MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy (EpimiRNA) Consortium
Research Areas
At a Glance
- Status: Active Consortium
- Year Launched: 2013
- Initiating Organization: European Comission Seventh Framework Programme (FP7)
- Initiator Type: Government
- Disease focus:
Epilepsy - Location: Europe
Abstract
The MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy (EpimiRNA) consortium aims to understand molecular mechanisms and diagnostics and develop novel therapeutics for epilepsy. The consortium aims to apply recent scientific breakthroughs that identified a new family of molecules that affect brain cell structure and function, called microRNAs, to better understand medical products targeted to epilepsy.
Mission
EpimiRNA aims to better understand the role of miRNAs in the pathogenesis of epilepsy.
The main aims of the EpimiRNA consortium include:
Consortium History
Sept. 1, 2013 – Project Start Date
Structure & Governance
The consortium is composed of investigators that participate in several working groups. The technical working groups include:
Financing
Funded by the European Union under the 7th Framework Programme under grant agreement n° 602130.
|
Homepage |
Points of Contact
Prof David Henshall - Coordinator
Royal College of Surgeons in Ireland
123 St Stephens Green
Dublin 2
Ireland
Phone: +353 14028629
Email: dhenshall@rcsi.ie
Sponsors & Partners
|
Royal College of Surgeons in Ireland |
|
Philipps Universitat Marburg |
|
Universitair Medisch Centrum Utrecht |
|
University College London |
|
University of Verona |
|
Universitatsklinikum Erlangen |
|
Duke University |
|
University of Campinas |
|
University of Aarhus/iNANO |
|
University of Southern Denmark |
|
Dixi Microtechniques |
|
Cerbomed GmbH |
|
Interna Technologies BV |
|
Bicoll GmbH |
|
BC Platforms |
|
GABO:mi |